These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27520520)

  • 1. The Therapeutic Role of Gangliosides in Neurological Disorders.
    Schneider JS
    CNS Drugs; 1994 Mar; 1(3):213-22. PubMed ID: 27520520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gangliosides. Their role in clinical neurology.
    Nobile-Orazio E; Carpo M; Scarlato G
    Drugs; 1994 Apr; 47(4):576-85. PubMed ID: 7516857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gangliosides and the Treatment of Neurodegenerative Diseases: A Long Italian Tradition.
    Fazzari M; Lunghi G; Chiricozzi E; Mauri L; Sonnino S
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
    Kusunoki S; Kaida K
    J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunobiology of Guillain-Barré syndromes.
    Willison HJ
    J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a rabbit model of neuropathy induced by immunization with gangliosides.
    Moyano AL; Comín R; Lardone RD; Alaniz ME; Theaux R; Irazoqui FJ; Nores GA
    J Neurol Sci; 2008 Sep; 272(1-2):110-4. PubMed ID: 18573503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganglioside enhancement of neuronal differentiation, plasticity, and repair.
    Gorio A
    CRC Crit Rev Clin Neurobiol; 1986; 2(3):241-96. PubMed ID: 3536311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monosialogangliosides, neuroprotection, and neuronal repair processes.
    Skaper SD; Leon A
    J Neurotrauma; 1992 May; 9 Suppl 2():S507-16. PubMed ID: 1613810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.
    Kusunoki S; Kaida K; Ueda M
    Biochim Biophys Acta; 2008 Mar; 1780(3):441-4. PubMed ID: 17976386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between parenteral gangliosides administration and the Guillain-Barré syndrome].
    Conceição I; Carvalho M; Alves M; Parreira E; Martins A; Ferro J; Sales-Luis ML
    Rev Neurol; 1999 Jun 1-15; 28(11):1033-5. PubMed ID: 10390766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoantibodies in Guillain-Barré Syndrome].
    Uchibori A; Chiba A
    Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of GM1 and GD1b antigens in the human peripheral nervous system.
    Kusunoki S; Chiba A; Tai T; Kanazawa I
    Muscle Nerve; 1993 Jul; 16(7):752-6. PubMed ID: 7685064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
    Nobile-Orazio E; Giannotta C; Briani C
    J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P
    Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell response in acute motor axonal neuropathy.
    Cencioni MT; Notturno F; Caporale CM; Creati B; Prencipe V; Battistini L; Uncini A
    Int J Immunopathol Pharmacol; 2009; 22(4):1043-50. PubMed ID: 20074468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of cerebral edema with GM1 ganglioside.
    Karpiak SE; Mahadik SP
    J Neurosci Res; 1984; 12(2-3):485-92. PubMed ID: 6094838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.